Beneficial effects of probiotic and food borne yeasts on human health

Nutrients

Volumn 2, Issue 4, 2010, Pages 449-473

  Moslehi Jenabian, Saloomeh ^a   Pedersen, Line Lindegaard ^a   Jespersen, Lene ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Folate; Mycotoxins; Phytate; Probiotics; S. cerevisiae var. boulardii; Yeasts

Indexed keywords

FOLIC ACID; MINERAL; MYCOTOXIN; PHYTATE; PROBIOTIC AGENT;

BEVERAGE; BIOAVAILABILITY; CELL WALL; DETOXIFICATION; ENTEROPATHY; FERMENTATION; FOOD; HEALTH STATUS; HUMAN; HYDROLYSIS; IMMUNOMODULATION; REVIEW; YEAST; YEAST CELL;

EID: 79952067123     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu2040449     Document Type: Review

References (155)

1. Qualified Presumption of Safety of Micro-organisms in Food and Feed of Micro-organisms in Food and Feed. In The EFSA's 2nd Scientific Colloquium Report; European Food Safety Authority: Parma, Italy, 2005.
2. Jespersen, L. Occurrence and taxonomic characteristics of strains of Saccharomyces cerevisiae predominant in African indigenous fermented foods and beverages. FEMS Yeast Res. 2003, 3, 191-200.
3. Maugeri, F.; Hernalsteens, S. Screening of yeast strains for transfructosylating activity. J. Mol. Catal. B Enzym. 2007, 49, 43-49.
4. Psomas, E.I.; Fletouris, D.J.; Litopoulou-Tzanetaki, E.; Tzanetakis, N. Assimilation of cholesterol by yeast strains isolated from infant feces and Feta cheese. J. Dairy Sci. 2003, 86, 3416-3422.
5. Klimek, M.; Wang, S.; Ogunkanmi, A. Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia. P. T. 2009, 34, 313-327.
6. Kogan, G.; Pajtinka, M.; Babincova, M.; Miadokova, E.; Rauko, P.; Slamenova, D.; Korolenko T. A. Yeast cell wall polysaccharides as antioxidants and antimutagens: Can they fight cancer? Minireview. Neoplasma 2008, 55, 387-393.
7. Fleet G.H.; Balia R. In Yeasts in Food and Beverages; Querol, A., Fleet, G.H., Eds.; Springer-Verlag: Berlin, Heidelberg, Germany, 2006; Vol. 2, Chapter 12, pp. 381-398.
8. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. In Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report; FAO/WHO: Geneva, Switzerland, 2001.
9. Psani, M.; Kotzekidou, P. Technological characteristics of yeast strains and their potential as starter adjuncts in Greek-style black olive fermentation. World J. Microbiol. Biotechnol. 2006, 22, 1329-1336.
10. Kumura, H.; Tanoue, Y.; Tsukahara, M.; Tanaka, T.; Shimazaki, K. Screening of dairy yeast strains for probiotic applications. J. Dairy Sci. 2004, 87, 4050-4056.
11. Sazawal, S.; Hiremath, G.; Dhingra, U.; Malik, P.; Deb, S.; Black, R.E. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect. Dis. 2006, 6, 374-382.
12. van der Aakühle A.; Jespersen L. The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene. Syst. Appl. Microbiol. 2003, 26, 564-571.
13. Hennequin, C.; Thierry, A.; Richard, G.F.; Lecointre, G.; Nguyen, H.V.; Gaillardin, C.; Dujon, B. Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains. J. Clin. Microbiol. 2001, 39, 551-559.
14. Edwards-Ingram, L.; Gitsham, P.; Burton, N.; Warhurst, G.; Clarke, I.; Hoyle, D.; Oliver, S. G.; Stateva, L. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Appl. Environ. Microbiol. 2007, 73, 2458-2467.
15. Fietto, J.L.; Araujo, R.S.; Valadao, F.N.; Fietto, L.G.; Brandao, R.L.; Neves, M.J.; Gomes, F.C.; Nicoli, J.R.; Castro, I.M. Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can. J. Microbiol. 2004, 50, 615-621.
16. Gedek, B.R. Adherence of Escherichia coli serogroup 0 157 and the Salmonella Typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 1999, 42, 261-264.
17. Tasteyre, A.; Barc, M.C.; Karjalainen, T.; Bourlioux, P.; Collignon, A. Inhibition of in vitro cell adherence of Clostridium difficile by Saccharomyces boulardii. Microb. Pathog. 2002, 32, 219-225.
18. Lessard, M.; Dupuis, M.; Gagnon, N.; Nadeau, E.; Matte, J.J.; Goulet, J.; Fairbrother, J.M. Administration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after Escherichia coli challenge. J. Anim Sci. 2009, 87, 922-934.
19. Wu, X.; Vallance, B.A.; Boyer, L.; Bergstrom, K.S.B.; Walker, J.; Madsen, K.; O'Kusky, J.R.; Buchan, A.M.; Jacobson, K. Saccharomyces boulardii ameliorates Citrobacter rodentiuminduced colitis through actions on bacterial virulence factors. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G295-G306.
20. Herek, O.; Kara, I.G.; Kaleli, I. Effects of antibiotics and Saccharomyces boulardii on bacterial translocation in burn injury. Surg. Today 2004, 34, 256-260.
21. Czerucka, D.; Dahan, S.; Mograbi, B.; Rossi, B.; Rampal, P. Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect. Immun. 2000, 68, 5998-6004.
22. Mumy, K.L.; Chen, X.H.; Kelly, C.P.; McCormick, B.A. Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G599-G609.
23. Rodrigues, A.C.; Nardi, R.M.; Bambirra, E.A.; Vieira, E.C.; Nicoli, J.R. Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. J. Appl. Bacteriol. 1996, 81, 251-256.
24. Castagliuolo, I.; LaMont, J.T.; Nikulasson, S.T.; Pothoulakis, C. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect. Immun. 1996, 64, 5225-5232.
25. Castagliuolo, I.; Riegler, M.F.; Valenick, L.; LaMont, J.T.; Pothoulakis, C. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect. Immun. 1999, 67, 302-307.
26. Pothoulakis, C.; Kelly, C.P.; Joshi, M.A.; Gao, N.; O'Keane, C.J.; Castagliuolo, I.; LaMont, J.T. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterol. 1993, 104, 1108-1115.
27. Czerucka, D.; Roux, I.; Rampal, P. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5'-cyclic monophosphate induction in intestinal cells. Gastroenterol. 1994, 106, 65-72.
28. Czerucka, D.; Rampal, P. Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Clsecretion in T84 cells. Dig. Dis. Sci. 1999, 44, 2359-2368.
29. Brandão, R.L.; Castro, I.M.; Bambirra, E.A.; Amaral, S.C.; Fietto, L.G.; Tropia, M.J.; Neves, M.J.; Dos Santos, R.G.; Gomes, N.C.; Nicoli, J.R. Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl. Environ. Microbiol. 1998, 64, 564-568.
30. Buts, J.P.; Dekeyser, N.; Stilmant, C.; Delem, E.; Smets, F.; Sokal, E. Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr. Res. 2006, 60, 24-29.
31. Dahan, S.; Dalmasso, G.; Imbert, V.; Peyron, J.F.; Rampal, P.; Czerucka, D. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect. Immun. 2003, 71, 766-773.
32. Dalmasso, G.; Loubat, A.; Dahan, S.; Calle, G.; Rampal, P.; Czerucka, D. Saccharomyces boulardii prevents TNF-α-induced apoptosis in EHEC-infected T84 cells. Res. Microbiol. 2006, 157, 456-465.
33. Chen, X.; Kokkotou, E.G.; Mustafa, N.; Bhaskar, K.R.; Sougioultzis, S.; O'Brien, M.; Pothoulakis, C.; Kelly, C.P. Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin Ainduced enteritis. J. Biol. Chem. 2006, 281, 24449-24454.
34. Sougioultzis, S.; Simeonidis, S.; Bhaskar, K.R.; Chen, X.; Anton, P.M.; Keates, S.; Pothoulakis, C.; Kelly, C.P. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-κB-mediated IL-8 gene expression. Biochem. Biophys. Res. Commun. 2006, 343, 69-76.
35. van der Aa Kühle, A.; Skovgaard, K.; Jespersen, L. In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. Int. J. Food Microbiol. 2005, 101, 29-39.
36. Klingberg, T.D.; Lesnik, U.; Arneborg, N.; Raspor, P.; Jespersen, L. Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits. FEMS Yeast Res. 2008, 8, 631-640.
37. Lee, S.K.; Kim, H.J.; Chi, S.G.; Jang, J.Y.; Nam, K.D.; Kim, N.H.; Joo, K.R.; Dong, S.H.; Kim, B.H.; Chang, Y.W.; Lee, J.I.; Chang, R. Saccharomyces boulardii activates expression of peroxisome proliferator-activated receptor-gamma in HT-29 cells. Korean J. Gastroenterol. 2005, 45, 328-334.
38. Su, C.G.; Wen, X.; Bailey, S.T.; Jiang, W.; Rangwala, S.M.; Keilbaugh, S.A.; Flanigan, A.; Murthy, S.; Lazar, M.A.; Wu, G.D. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J. Clin. Invest. 1999, 104, 383-389.
39. Dalmasso, G.; Cottrez, F.; Imbert, V.; Lagadec, P.; Peyron, J.F.; Rampal, P.; Czerucka, D.; Groux, H.; Foussat, A.; Brun, V. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterol. 2006, 131, 1812-1825.
40. Dijkstra, G.; Moshage, H.; van Dullemen, H.M.; de Jager-Krikken, A.; Tiebosch, A.T.; Kleibeuker, J.H.; Jansen, P.L.; van, G.H. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J. Pathol. 1998, 186, 416-421.
41. Girard, P.; Pansart, Y.; Gillardin, J.M. Inducible nitric oxide synthase involvement in the mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhoea in rats. Nitric. Oxide. 2005, 13, 163-169.
42. Caetano, J.A.; Parames, M.T.; Babo, M.J.; Santos, A.; Ferreira, A.B.; Freitas, A.A.; Coelho, M.R.; Mateus, A.M. Immunopharmacological effects of Saccharomyces boulardii in healthy human volunteers. Int. J. Immunopharmacol. 1986, 8, 245-259.
43. Buts, J.P.; Bernasconi, P.; Vaerman, J.P.; Dive, C. Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig. Dis. Sci. 1990, 35, 251-256.
44. Qamar, A.; Aboudola, S.; Warny, M.; Michetti, P.; Pothoulakis, C.; LaMont, J.T.; Kelly, C.P. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect. Immun. 2001, 69, 2762-2765.
45. Rodrigues, A.C.; Cara, D.C.; Fretez, S.H.; Cunha, F.Q.; Vieira, E.C.; Nicoli, J.R.; Vieira, L.Q. Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J. Appl. Microbiol. 2000, 89, 404-414.
46. Buts, J.P.; Bernasconi, P.; Van Craynest, M.P.; Maldague, P.; De, M.R. Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr. Res. 1986, 20, 192-196.
47. Jahn, H.U.; Ullrich, R.; Schneider, T.; Liehr, R.M.; Schieferdecker, H.L.; Holst, H.; Zeitz, M. Immunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteers. Digestion 1996, 57, 95-104.
48. Buts, J.P.; De, K.N.; Marandi, S.; Hermans, D.; Sokal, E.M.; Chae, Y.H.; Lambotte, L.; Chanteux, H.; Tulkens, P.M. Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats. Gut 1999, 45, 89-96.
49. Buts, J.P.; De, K.N.; De, R.L. Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines. Pediatr. Res. 1994, 36, 522-527.
50. Bowling, T.E.; Raimundo, A.H.; Grimble, G.K.; Silk, D.B. Reversal by short-chain fatty acids of colonic fluid secretion induced by enteral feeding. Lancet 1993, 342, 1266-1268.
51. Schneider, S.M.; Le Gall, P.; Girard-Pipau, E.; Piche, T.; Pompei, A.; Nano, J.L.; Hebuterne, X.; Rampal, P. Total artificial nutrition is associated with major changes in the fecal flora. Eur. J. Nutr. 2000, 39, 248-255.
52. Schneider, S.M.; Girard-Pipau, F.; Filippi, J.; Hebuterne, X.; Moyse, D.; Hinojosa, G.C.; Pompei, A.; Rampal, P. Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J. Gastroenterol. 2005, 11, 6165-6169.
53. Buts, J.P.; De, K.N.; Stilmant, C.; Sokal, E.; Marandi, S. Saccharomyces boulardii enhances Nterminal peptide hydrolysis in suckling rat small intestine by endoluminal release of a zincbinding metalloprotease. Pediatr. Res. 2002, 51, 528-534.
54. De Llanos, R.; Querol, A.; Peman, J.; Gobernado, M.; Fernandez-Espinar, M.T. Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. Int. J. Food Microbiol. 2006, 110, 286-290.
55. Hennequin, C.; Kauffmann-Lacroix, C.; Jobert, A.; Viard, J.P.; Ricour, C.; Jacquemin, J.L.; Berche, P. Possible role of catheters in Saccharomyces boulardii fungemia. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19, 16-20.
56. Lherm, T.; Monet, C.; Nougiere, B.; Soulier, M.; Larbi, D.; Le Gall, C.; Caen, D.; Malbrunot, C. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med. 2002, 28, 797-801.
57. Katz, J.A. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea. J. Clin. Gastroenterol. 2006, 40, 249-255.
58. McFarland, L.V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am. J. Gastroenterol. 2006, 101, 812-822.
59. Rohde, C.L.; Bartolini, V.; Jones, N. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea. Nutr. Clin. Pract. 2009, 24, 33-40.
60. Beaugerie, L.; Petit, J.C. Antibiotic-associated diarrhoea. Best Pract. Res. Clin. Gastroenterol. 2004, 18, 337-352.
61. Asha, N.J.; Tompkins, D.; Wilcox, M.H. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J. Clin. Microbiol. 2006, 44, 2785-2791.
62. Kotowska, M.; Albrecht, P.; Szajewska, H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment. Pharmacol. Ther. 2005, 21, 583-590.
63. Surawicz, C.M.; McFarland, L.V.; Greenberg, R.N.; Rubin, M.; Fekety, R.; Mulligan, M. E.; Garcia, R. J.; Brandmarker, S.; Bowen, K.; Borjal, D.; Elmer, G. W. The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis. 2000, 31, 1012-1017.
64. Sanders, J.W.; Tribble, D.R. Diarrhea in the returned traveler. Curr. Gastroenterol. Rep. 2001, 3, 304-314.
65. McFarland, L.V. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel. Med. Infect. Dis. 2007, 5, 97-105.
66. Szajewska, H.; Skorka, A.; Dylag, M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment. Pharmacol. Ther. 2007, 25, 257-264.
67. Szajewska, H.; Ruszczynski, M.; Radzikowski, A. Probiotics in the prevention of antibioticassociated diarrhea in children: a meta-analysis of randomized controlled trials. J. Pediatr. 2006, 149, 367-372.
68. Bleichner, G.; Blehaut, H.; Mentec, H.; Moyse, D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients - A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med. 1997, 23, 517-523.
69. James, J.S. Diarrhea, and the experimental treatment Saccharomyces boulardii. AIDS Treat. News 1995, 1-4.
70. Saint-Marc, T.; Rossello-Prats, L.; Touraine, J.L. Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS. Ann. Med. Interne (Paris) 1991, 142, 64-65.
71. Maupas, J.; Champemont, P.; Delforge, M. Treatment of irritable bowel syndrome with Saccharomyces boulardii: A double-blind, placebo-controlled study. Med. Chir. Dig. 1983, 12, 77-79.
72. Plein, K.; Hotz, J. Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohns-disease with special respect to chronic diarrhea - a pilot-study. Z Gastroenterol. 1993, 31, 129-134.
73. Guslandi, M.; Mezzi, G.; Sorghi, M.; Testoni, P.A. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig. Dis. Sci. 2000, 45, 1462-1464.
74. Guslandi, M.; Giollo, P.; Testoni, P.A. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 2003, 15, 697-698.
75. Vilela, E.G.; Ferrari, M.D.D.; Torres, H.O.D.; Pinto, A.G.; Aguirre, A.C.C.; Martins, F.P.; Goulart, E.M.A.; Da Cunha, A.S. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand. J. Gastroenterol. 2008, 43, 842-848.
76. Lopez, H.W.; Leenhardt, F.; Coudray, C.; Remesy, C. Minerals and phytic acid interactions: is it a real problem for human nutrition? Int. J. Food Sci. Technol. 2002, 37, 727-739.
77. Maga, J.A. Phytate - Its Chemistry, Occurrence, Food Interactions, Nutritional Significance, and Methods of Analysis. J. Agric. Food Chem. 1982, 30, 1-9.
78. Vohra, A.; Satyanarayana, T. Phytases: Microbial sources, production, purification, and potential biotechnological applications. Crit. Rev. Biotechnol. 2003, 23, 29-60.
79. Reddy, N.R.; Pierson, M.D. Reduction in antinutritional and toxic components in plant foods (A) by fermentation. Food Res. Int. 1994, 27, 281-290.
80. Vucenik, I.; Shamsuddin, A.M. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: From laboratory to clinic. J. Nutr. 2003, 133, 3778S-3784S.
81. Vucenik, I.; Shamsuddin, A.M. Protection against cancer by dietary IP6 and inositol. Nutr. Cancer 2006, 55, 109-125.
82. Konietzny, U.; Greiner, R. Molecular and catalytic properties of phytate-degrading enzymes (phytases). Int. J. Food Sci. Technol. 2002, 37, 791-812.
83. Türk, M.; Carlsson, N.G.; Sandberg, A.S. Reduction in the levels of phytate during wholemeal bread making; Effect of yeast and wheat phytases. J. Cereal Sci. 1996, 23, 257-264.
84. Sandberg, A.S. The effect of food processing on phytate hydrolysis and availability of iron and zinc. Adv. Exp. Med. Biol. 1991, 289, 499-508.
85. Navert, B.; Sandstrom, B.; Cederblad, A. Reduction of the phytate content of bran by leavening in bread and its effect on zinc absorption in man. Br. J. Nutr. 1985, 53, 47-53.
86. Sandberg, A.S.; Hasselblad, C.; Hasselblad, K.; Hulten, L. The effect of wheat bran on the absorption of minerals in the small intestine. Br. J. Nutr. 1982, 48, 185-191.
87. Haefner, S.; Knietsch, A.; Scholten, E.; Braun, J.; Lohscheidt, M.; Zelder, O. Biotechnological production and applications of phytases. Appl. Microbiol. Biotechnol. 2005, 68, 588-597.
88. Quan, C.S.; Fan, S.D.; Zhang, L.H.; Wang, Y.J.; Ohta, Y. Purification and properties of a phytase from Candida krusei WZ-001. J. Biosci. Bioeng. 2002, 94, 419-425.
89. Segueilha, L.; Lambrechts, C.; Boze, H.; Moulin, G.; Galzy, P. Purification and properties of the phytase from Schwanniomyces castellii. J. Ferment. Bioeng. 1992, 74, 7-11.
90. Ragon, M.; Aumelas, A.; Chemardin, P.; Galvez, S.; Moulin, G.; Boze, H. Complete hydrolysis of myo-inositol hexakisphosphate by a novel phytase from Debaryomyces castellii CBS 2923. Appl. Microbiol. Biotechnol. 2008, 78, 47-53.
91. Sano, K.; Fukuhara, H.; Nakamura, Y. Phytase of the yeast Arxula adeninivorans. Biotechnol. Lett. 1999, 21, 33-38.
92. Olstorpe, M.; Schnurer, J.; Passoth, V. Screening of yeast strains for phytase activity. FEMS Yeast Res. 2009, 9, 478-488.
93. Vohra, A.; Satyanarayana, T. Phytase production by the yeast, Pichia anomala. Biotechnol. Lett. 2001, 23, 551-554.
94. Nakamura, Y.; Fukuhara, H.; Sano, K. Secreted phytase activities of yeasts. Biosci. Biotechnol. Biochem. 2000, 64, 841-844.
95. van Staden, J.; den Haan, R.; van Zyl, W. H.; Botha, A.; Viljoen-Bloom, M. Phytase activity in Cryptococcus laurentii ABO 510. FEMS Yeast Res. 2007, 7, 442-448.
96. Bindu, S.; Somashekar, D.; Joseph, R. A comparative study on permeabilization treatments for in situ determination of phytase of Rhodotorula gracilis. Lett. Appl. Microbiol. 1998, 27, 336-340.
97. Lim, M.H.; Lee, O.H.; Chin, J.E.; Ko, H.M.; Kim, I.C.; Lee, H.B.; Im, S.Y.; Bai, S. Simultaneous degradation of phytic acid and starch by an industrial strain of Saccharomyces cerevisiae producing phytase and alpha-amylase. Biotechnol. Lett. 2008, 30, 2125-2130.
98. Veide, J.; Andlid, T. Improved extracellular phytase activity in Saccharomyces cerevisiae by modifications in the PHO system. Int. J. Food Microbiol. 2006, 108, 60-67.
99. Andlid, T.A.; Veide, J.; Sandberg, A.S. Metabolism of extracellular inositol hexaphosphate (phytate) by Saccharomyces cerevisiae. Int. J. Food Microbiol. 2004, 97, 157-169.
100. Türk, M.; Sandberg, A. S.; Carlsson, N. G.; Andlid, T. Inositol hexaphosphate hydrolysis by Baker's yeast. Capacity, kinetics, and degradation products. J. Agric. Food Chem. 2000, 48, 100-104.
101. Harland, B. F.; Frolich, W. Effects of phytase from 3 yeasts on phytate reduction in Norwegian whole wheat-flour. Cereal Chem. 1989, 66, 357-358.
102. Türk, M.; Sandberg, A.S. Phytate Degradation During Breadmaking-Effect of Phytase Addition. J. Cereal Sci. 1992, 15, 281-294.
103. Haraldsson, A.K.; Veide, J.; Andlid, T.; Alminger, M.L.; Sandberg, A.S. Degradation of phytate by high-phytase Saccharomyces cerevisiae strains during simulated gastrointestinal digestion. J. Agric. Food Chem. 2005, 53, 5438-5444.
104. Reale, A.; Mannina, L.; Tremonte, P.; Sobolev, A.P.; Succi, M.; Sorrentino, E.; Coppola, R. Phytate degradation by lactic acid bacteria and yeasts during the wholemeal dough fermentation: a P-31 NMR study. J. Agric. Food Chem. 2004, 52, 6300-6305.
105. Lopez, H.W.; Duclos, V.; Coudray, C.; Krespine, V.; Feillet-Coudray, C.; Messager, A.; Demigne, C.; Remesy, C. Making bread with sourdough improves mineral bioavailability from reconstituted whole wheat flour in rats. Nutrition 2003, 19, 524-530.
106. Chaoui, A.; Faid, M.; Belhcen, R. Effect of natural starters used for sourdough bread in Morocco on phytate biodegradation. East Mediterr. Health J. 2003, 9, 141-147.
107. Antai, S.P.; Nkwelang, G. Reduction of some toxicants in Icacina mannii by fermentation with Saccharomyces cerevisiae. Plant Foods Hum. Nutr. 1999, 53, 103-111.
108. Bilgicli, N.; Elgun, A.; Turker, S. Effects of various phytase sources on phytic acid content, mineral extractability and protein digestibility of tarhana. Food Chem. 2006, 98, 329-337.
109. Gregory, J.F. Chemical and nutritional aspects of folate research: analytical procedures, methods of folate synthesis, stability, and bioavailability of dietary folates. Adv. Food Nutr. Res. 1989, 33, 1-101.
110. Hanson, A.D.; Roje, S. One-carbon metabolism in higher plants. Annu. Rev. Plant Physiol. Plant Mol. Biol. 2001, 52, 119-137.
111. Scott, J.; Rebeille, F.; Fletcher, J. Folic acid and folates: the feasibility for nutritional enhancement in plant foods. J. Sci. Food Agric. 2000, 80, 795-824.
112. Bailey, L.B.; Rampersaud, G.C.; Kauwell, G.P. A. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: Evolving science. J. Nutr. 2003, 133, 1961S-1968S.
113. Cordero, J.F.; Do, A.; Berry, R.J. Review of interventions for the prevention and control of folate and vitamin B-12 deficiencies. Food Nutr. Bull. 2008, 29, S188-S195.
114. Ward, M. Homocysteine, folate, and cardiovascular disease. Int. J. Vitam. Nutr. Res. 2001, 71, 173-178.
115. Duthie, S.J. Folic acid deficiency and cancer: mechanisms of DNA instability. Br. Med. Bull. 1999, 55, 578-592.
116. Wang, H.X. Vitamin B-12, folate, and Alzheimer's disease. Drug Dev. Res. 2002, 56, 111-122.
117. de Bree, A.; van, D.M.; Brouwer, I.A.; van het Hof, K.H.; Steegers-Theunissen, R.P. Folate intake in Europe: recommended, actual and desired intake. Eur. J. Clin. Nutr. 1997, 51, 643-660.
118. Letsky, E.A. Erythropoiesis in Pregnancy. J. Perinat. Med. 1995, 23, 39-45.
119. Patring, J.D.; Jastrebova, J.A.; Hjortmo, S.B.; Andlid, T.A.; Jagerstad, I.M. Development of a simplified method for the determination of folates in baker's yeast by HPLC with ultraviolet and fluorescence detection. J. Agric. Food Chem. 2005, 53, 2406-2411.
120. Hjortmo, S.; Patring, J.; Andlid, T. Growth rate and medium composition strongly affect folate content in Saccharomyces cerevisiae. Int. J. Food Microbiol. 2008, 123, 93-100.
121. Hjortmo, S.; Patring, J.; Jastrebova, J.; Andlid, T. Inherent biodiversity of folate content and composition in yeasts. Trends Food Sci. Technol. 2005, 16, 311-316.
122. Hjortmo, S.; Patring, J.; Jastrebova, J.; Andlid, T. Biofortification of folates in white wheat bread by selection of yeast strain and process. Int. J. Food Microbiol. 2008, 127, 32-36.
123. Kariluoto, S.; Vahteristo, L.; Salovaara, H.; Katina, K.; Liukkonen, K.H.; Piironen, V. Effect of baking method and fermentation on folate content of rye and wheat breads. Cereal Chem. 2004, 81, 134-139.
124. Osseyi, E.S.; Wehling, R.L.; Albrecht, J.A. HPLC determination of stability and distribution of added folic acid and some endogenous folates during breadmaking. Cereal Chem. 2001, 78, 375-378.
125. Jägerstad, M.; Piironen, V.; Walker, C.; Ros, G.; Carnovale, E.; Holasova, M.; Nau, H. Increasing natural-food folates through bioprocessing and biotechnology. Trends Food Sci. Technol. 2005, 16, 298-306.
126. Kariluoto, S.; Aittamaa, M.; Korhola, M.; Salovaara, H.; Vahteristo, L.; Piironen, V. Effects of yeasts and bacteria on the levels of folates in rye sourdoughs. Int. J. Food Microbiol. 2006, 106, 137-143.
127. Zubillaga, M.; Weill, R.; Postaire, E.; Goldman, C.; Caro, R.; Boccio, J. Effect of probiotics and functional foods and their use in different diseases. Nutr. Res. 2001, 21, 569-579.
128. Witthuhn, R.C.; Schoeman, T.; Britz, T.J. Characterisation of the microbial population at different stages of Kefir production and Kefir grain mass cultivation. Int. Dairy J. 2005, 15, 383-389.
129. Patring, J.D.M.; Hjortmo, S.B.; Jastrebova, J.A.; Svensson, U.K.; Andlid, T.A.; Jägerstad, I.M. Characterization and quantification of folates produced by yeast strains isolated from kefir granules. Eur. Food Res. Technol. 2006, 223, 633-637.
130. Hjortmo, S.B.; Hellstrom, A.M.; Andlid, T.A. Production of folates by yeasts in Tanzanian fermented togwa. FEMS Yeast Res. 2008, 8, 781-787.
131. Sweeney, M.J.; Dobson, A.D. Mycotoxin production by Aspergillus, Fusarium and Penicillium species. Int. J. Food Microbiol. 1998, 43, 141-158.
132. Bhat, R.V. Mould deterioration of agricultural commodities during transit: problems faced by developing countries. Int. J. Food Microbiol. 1988, 7, 219-225.
133. Schatzmayr, G.; Zehner, F.; Taubel, M.; Schatzmayr, D.; Klimitsch, A.; Loibner, A.P.; Binder, E. M. Microbiologicals for deactivating mycotoxins. Mol. Nutr. Food Res. 2006, 50, 543-551.
134. Galvano, F.; Piva, A.; Ritieni, A.; Galvano, G. Dietary strategies to counteract the effects of mycotoxins: a review. J. Food Prot. 2001, 64, 120-131.
135. Kabak, B.; Dobson, A.D.; Var, I. Strategies to prevent mycotoxin contamination of food and animal feed: a review. Crit Rev. Food Sci. Nutr. 2006, 46, 593-619.
136. Shephard, G.S. Impact of mycotoxins on human health in developing countries. Food Addit. Contam. 2008, 25, 146-151.
137. Wu, Q.; Jezkova, A.; Yuan, Z.; Pavlikova, L.; Dohnal, V.; Kuca, K. Biological degradation of aflatoxins. Drug Metab. Rev. 2009, 41, 1-7.
138. Moss, M.O.; Long, M.T. Fate of patulin in the presence of the yeast Saccharomyces cerevisiae. Food Addit. Contam. 2002, 19, 387-399.
139. Böswald, C.; Engelhardt, G.; Vogel, H.; Wallnofer, P.R. Metabolism of the Fusarium mycotoxins zearalenone and deoxynivalenol by yeast strains of technological relevance. Nat. Toxins. 1995, 3, 138-144.
140. Scott, P.M.; Kanhere, S.R.; Lawrence, G.A.; Daley, E.F.; Farber, J.M. Fermentation of wort containing added ochratoxin A and fumonisins B1 and B2. Food Addit. Contam. 1995, 12, 31-40.
141. Garda, J.; Macedo, R.M.; Faria, R.; Bernd, L.; Dors, G.C.; Badiale-Furlong, E. Alcoholic fermentation effects on malt spiked with trichothecenes. Food Control. 2005, 16, 423-428.
142. Péteri, Z.; Teren, J.; Vagvolgyi, C.; Varga, J. Ochratoxin degradation and adsorption caused by astaxanthin-producing yeasts. Food Microbiol. 2007, 24, 205-210.
143. Shetty, P.H.; Jespersen, L. Saccharomyces cerevisiae and lactic acid bacteria as potential mycotoxin decontaminating agents. Trends Food Sci. Technol. 2006, 17, 48-55.
144. Girish, C.K.; Devegowda, C. Efficacy of glucomannan-containing yeast product (Mycosorb (R)) and hydrated sodium calcium aluminosilicate in preventing the individual and combined toxicity of aflatoxin and T-2 toxin in commercial broilers. Asian-australas. J. Anim. Sci. 2006, 19, 877-883.
145. Raju, M.V.L.N.; Devegowda, G. Esterified-glucomannan in broiler chicken diets-contaminated with aflatoxin, ochratoxin and T-2 toxin: Evaluation of its binding ability (in vitro) and efficacy as immunomodulator. Asian-australas. J. Anim. Sci. 2002, 15, 1051-1056.
146. Aravind, K.L.; Patil, V.S.; Devegowda, G.; Umakantha, B.; Ganpule, S.P. Efficacy of esterified glucomannan to counteract mycotoxicosis in naturally contaminated feed on performance and serum biochemical and hematological parameters in broilers. Poult. Sci. 2003, 82, 571-576.
147. Bejaoui, H.; Mathieu, F.; Taillandier, P.; Lebrihi, A. Ochratoxin A removal in synthetic and natural grape juices by selected oenological Saccharomyces strains. J. Appl. Microbiol. 2004, 97, 1038-1044.
148. Yiannikouris, A.; Francois, J.; Poughon, L.; Dussap, C.G.; Bertin, G.; Jeminet, G.; Jouany, J.P. Adsorption of Zearalenone by beta-D-glucans in the Saccharomyces cerevisiae cell wall. J. Food Prot. 2004, 67, 1195-1200.
149. Raju, M.V.; Devegowda, G. Influence of esterified-glucomannan on performance and organ morphology, serum biochemistry and haematology in broilers exposed to individual and combined mycotoxicosis (aflatoxin, ochratoxin and T-2 toxin). Br. Poult. Sci. 2000, 41, 640-650.
150. Sabater-Vilar, M.; Malekinejad, H.; Selman, M.H.; van der Doelen, M.A.; Fink-Gremmels, J. In vitro assessment of adsorbents aiming to prevent deoxynivalenol and zearalenone mycotoxicoses. Mycopathologia 2007, 163, 81-90.
151. Baptista, A.S.; Horii, J.; Calori-Domingues, M.A.; da Gloria, E.M.; Salgado, J.M.; Vizioli, M.R. The capacity of manno-oligosaccharides, thermolysed yeast and active yeast to attenuate aflatoxicosis. World J. Microbiol. Biotechnol. 2004, 20, 475-481.
152. Madrigal-Santillán, E.; Madrigal-Bujaidar, E.; Márquez-Márquez, R.; Reyes, A. Antigenotoxic effect of Saccharomyces cerevisiae on the damage produced in mice fed with aflatoxin B1 contaminated corn. Food Chem. Toxicol. 2006, 44, 2058-2063.
153. Caridi, A.; Galvano, F.; Tafur, A.; Ritieni, A. In-vitro screening of Saccharomyces strains for ochratoxin A removal from liquid medium. Ann. Microbiol. 2006, 56, 135-137.
154. Caridi, A. New perspectives in safety and quality enhancement of wine through selection of yeasts based on the parietal adsorption activity. Int. J. Food Microbiol. 2007, 120, 167-172.
155. Shetty, P.H.; Hald, B.; Jespersen, L. Surface binding of aflatoxin B1 by Saccharomyces cerevisiae strains with potential decontaminating abilities in indigenous fermented foods. Int. J. Food Microbiol. 2007, 113, 41-46.